Stay updated on Ibrutinib, Fludarabine, Pembrolizumab in CLL Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib, Fludarabine, Pembrolizumab in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib, Fludarabine, Pembrolizumab in CLL Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed on the page, replacing v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:39:40.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added a Locations section listing Maryland as a study site. Removed the HHS Vulnerability Disclosure link and the older Maryland Locations entry.
    Difference
    0.2%
    Check dated 2025-12-23T17:15:21.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2. This change does not modify the study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2025-11-24T20:59:50.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Removal of the government funding/status notice; core study information including interventions, eligibility criteria, and outcomes remains unchanged. The administrative notice removed does not affect the study details or enrollment processes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:16:44.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The changes are limited to minor formatting and wording updates on the Study Details page and do not affect core content such as eligibility criteria, outcomes, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T12:53:08.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    3%
    Check dated 2025-10-05T17:39:33.000Z thumbnail image

Stay in the know with updates to Ibrutinib, Fludarabine, Pembrolizumab in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib, Fludarabine, Pembrolizumab in CLL Clinical Trial page.